Climb Bio (CLYM) Change in Acquisitions & Divestments (2022 - 2026)

Climb Bio's Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $31.9 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 99.37% year-over-year to $31.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127.0 million (up 452.18% YoY) and the FY2025 annual result came in at $111.1 million, up 435.41% from the prior year.
• Change in Acquisitions & Divestments was $31.9 million for Q1 2026 at Climb Bio, up from $30.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $55.3 million in Q3 2022 and bottomed at $7.0 million in Q4 2024.
• A 5-year average of $27.6 million and a median of $25.5 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments sank 80.95% — and 2025, when it soared 336.26%.
• Climb Bio's Change in Acquisitions & Divestments stood at $21.0 million in 2022, then soared by 75.06% to $36.7 million in 2023, then sank by 80.95% to $7.0 million in 2024, then soared by 336.26% to $30.5 million in 2025, then advanced by 4.47% to $31.9 million in 2026.
• Business Quant data shows CLYM's Change in Acquisitions & Divestments at $31.9 million in Q1 2026, $30.5 million in Q4 2025, and $39.1 million in Q3 2025.